CERO logo

CERo Therapeutics Holdings, Inc. (CERO)

Profile

Full Name

CERo Therapeutics Holdings, Inc.

Ticker

NASDAQ: CERO

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

November 30, 2021

Indexes

Not included

Website

https://www.cero.bio

Employees

8

Key Details

Price

$8.39(-0.42%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

$0.00(+100.00% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $8.39
    CERO price is $8.39

    30-Day Relative Volume

    0.98
    CERO 30-day relative volume is 0.98

    Price Performance

    Price Today change

    -0.42%
    CERO price is down -0.42% today

    Price YTD change

    -93.01%
    CERO price is down -93.01% since January 1st

    Price 1-year change

    -96.96%
    CERO price is down -96.96% year-on-year

    Price 3-year change

    -99.96%
    CERO price is down -99.96% over the past 3 years

    Price Range

    Price All-time high

    $25.60K
    CERO price is currently -99.97% below its historical high of $25.60 thousand

    Price 3-year low

    $6.71
    CERO price is currently +25.04% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $10.11M
    CERO market capitalization is $10.11 million

    Market cap 3-year change

    -94.55%
    CERO market capitalization is down -94.55% over the past 3 years

    Market cap All-time high

    $189.52M
    CERO market capitalization is currently -94.66% below its historical high of $189.52 million

    Market cap sector rank

    16.75%
    CERO market capitalization is higher than 16.75% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +4645.67%
    CERO shares outstanding is up +4645.67% year-on-year

    Shares Outstanding 3-Year Change

    +13002.17%
    CERO shares outstanding is up +13002.17% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.51
    CERO beta is 0.51

    200-day SMA

    $71.99
    CERO price is currently -88.35% below its 200-day simple moving average

    50-day SMA

    $8.70
    CERO price is currently -3.60% below its 50-day simple moving average

    RSI

    51.31
    CERO 14-day relative strength index is 51.31

    Volume

    0.98
    CERO 30-day relative volume is 0.98

    ATR

    $0.47
    CERO average true range is $0.47

    10-day Historical Volatility

    60.92%
    CERO 10-day historical volatility is 60.92%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    CERO annual revenue is $0.00

    Revenue Analysts estimate

    -
    CERO annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    0%
    CERO annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.61%
    CERO annual revenue is higher than 28.61% of companies in Healthcare sector

    EPS

    EPS

    $0.00
    CERO annual earnings per share is $0.00

    EPS Analysts estimate

    -$15.39
    CERO annual earnings per share is currently -100.00% lower than the consensus analysts' forecast

    EPS 1-year change

    +100%
    CERO annual earnings per share is up +100% year-on-year

    EPS Sector rank

    82.57%
    CERO annual earnings per share is higher than 82.57% of companies in Healthcare sector

    Profit

    Gross profit

    -$1.16M
    CERO annual gross profit is -$1.16 million

    Gross margin

    -
    CERO annual gross profit margin value is unknown

    Operating profit

    -$16.20M
    CERO annual operating income is -$16.20 million

    Operating margin

    -
    CERO annual operating profit margin value is unknown

    Net income

    -$8.30M
    CERO annual net profit is -$8.30 million

    Net margin

    -
    CERO annual net profit margin value is unknown

    Expenses

    Total expenses

    $8.30M
    CERO annual total expenses is $8.30 million

    Operating expenses

    $15.03M
    CERO annual total operating expenses is $15.03 million

    Cost of goods sold

    $1.16M
    CERO annual cost of goods sold is $1.16 million

    Selling, general & administrative expenses

    $0.00
    CERO annual SGA is $0.00

    Depreciation and amortization

    $1.16M
    CERO annual depreciation & amortization is $1.16 million

    Interest expense

    $0.00
    CERO annual interest expense is $0.00

    Income tax

    $0.00
    CERO annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$16.20M
    CERO annual earnings before interest & taxes is -$16.20 million

    EBITDA

    -$15.03M
    CERO annual EBITDA is -$15.03 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $7.50M
    CERO annual total assets is $7.50 million

    Non current assets

    $3.79M
    CERO annual long term assets is $3.79 million

    Current assets

    $3.71M
    CERO annual total current assets is $3.71 million

    Cash and cash equivalents

    $3.33M
    CERO annual cash & cash equivalents is $3.33 million

    Accounts receivable

    -
    CERO annual accounts receivable value is unknown

    Inventory

    $0.00
    CERO annual inventory is $0.00

    Liabilities

    Total liabilities

    $8.10M
    CERO annual total liabilities is $8.10 million

    Long term liabilities

    $699.10K
    CERO annual total long term liabilities is $699.10 thousand

    Current liabilities

    $7.40M
    CERO annual total current liabilities is $7.40 million

    Accounts payable

    $4.51M
    CERO annual accounts payable is $4.51 million

    Debt

    Total debt

    $1.58M
    CERO annual total debt is $1.58 million

    Total debt 1-year change

    -46.49%
    CERO annual total debt is down -46.49% year-on-year

    Long term debt

    $699.10K
    CERO annual long term debt is $699.10 thousand

    Short term debt

    $876.40K
    CERO annual short term debt is $876.40 thousand

    Equity & Capital

    Shareholders equity

    -$599.10K
    CERO annual stockholders equity is -$599.10 thousand

    Book value

    -$5.07M
    CERO annual book value is -$5.07 million

    Retained earnings

    -$70.92M
    CERO annual retained earnings is -$70.92 million

    Working capital

    -$3.80M
    CERO annual working capital is -$3.80 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$12.92M
    CERO annual cash flow from operations is -$12.92 million

    Cash from operations 1-year change

    -123.07%
    CERO annual cash flow from operations is down -123.07% year-on-year

    Cash from investing

    $0.00
    CERO annual cash flow from investing activities is $0.00

    Cash from investing 1-year change

    0%
    CERO annual cash flow from investing activities has remained unchanged year-on-year

    Cash from financing

    $13.73M
    CERO annual cash flow from financing activities is $13.73 million

    Cash from financing 1-year change

    +2301.19%
    CERO annual cash flow from financing activities is up +2301.19% year-on-year

    CAPEX

    CAPEX

    $0.00
    CERO annual capital expenditures is $0.00

    CAPEX 1-year change

    0%
    CERO annual capital expenditures has remained unchanged year-on-year

    Free Cash Flow

    Free cash flow

    -$12.92M
    CERO annual free cash flow is -$12.92 million

    Free cash flow 1-year change

    -123.07%
    CERO annual free cash flow is down -123.07% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    CERO annual gross profit margin value is unknown

    Operating margin

    -
    CERO annual operating profit margin value is unknown

    Net margin

    -
    CERO annual net profit margin value is unknown

    ROA & ROE

    ROA

    -131.52%
    CERO annual return on assets is -131.52%

    ROE

    1386.15%
    CERO annual return on equity is 1386.15%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    CERO price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    CERO price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -3.78
    CERO price to book ratio is -3.78

    PB ratio Sector rank

    6.83%
    CERO price to book ratio is higher than 6.83% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    CERO price to sales ratio value is unknown

    PS ratio Sector rank

    -
    CERO price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $6.28M
    CERO enterprise value is $6.28 million

    Enterprise value Sector rank

    20%
    CERO enterprise value is higher than 20% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.41
    CERO EV/EBITDA is -0.41

    EV/EBITDA Sector rank

    54.09%
    CERO EV/EBITDA is higher than 54.09% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    0.49
    CERO annual current ratio is 0.49

    Quick ratio

    0.50
    CERO annual quick ratio is 0.50

    Leverage

    Debt to equity

    -2.63
    CERO annual debt to equity ratio is -2.63

    Interest coverage ratio

    -
    CERO annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    CERO piotroski f-score value is unknown

    Altman Z-Score

    -20.22
    CERO altman z-score is -20.22

    Analyst ratings

    Recent major analysts updates

    Aug 4, 25 D. Boral Capital
    Buy
    Jun 24, 25 D. Boral Capital
    Buy
    Jun 23, 25 D. Boral Capital
    Buy
    May 30, 25 D. Boral Capital
    Hold
    May 19, 25 Maxim Group
    Buy
    Apr 25, 25 D. Boral Capital
    Buy
    Apr 23, 25 D. Boral Capital
    Buy
    Apr 22, 25 D. Boral Capital
    Buy

    Institutional Ownership

    Screeners with CERO included

    Growing Shares Outstanding
    US stocks
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Biotech Companies
    • What is the ticker symbol for CERo Therapeutics Holdings, Inc.?
    • Does CERo Therapeutics Holdings, Inc. pay dividends?
    • What sector is CERo Therapeutics Holdings, Inc. in?
    • What industry is CERo Therapeutics Holdings, Inc. in?
    • What country is CERo Therapeutics Holdings, Inc. based in?
    • When did CERo Therapeutics Holdings, Inc. go public?
    • Is CERo Therapeutics Holdings, Inc. in the S&P 500?
    • Is CERo Therapeutics Holdings, Inc. in the NASDAQ 100?
    • Is CERo Therapeutics Holdings, Inc. in the Dow Jones?
    • When does CERo Therapeutics Holdings, Inc. report earnings?

    What is the ticker symbol for CERo Therapeutics Holdings, Inc.?

    The ticker symbol for CERo Therapeutics Holdings, Inc. is NASDAQ:CERO

    Does CERo Therapeutics Holdings, Inc. pay dividends?

    No, CERo Therapeutics Holdings, Inc. does not pay dividends

    What sector is CERo Therapeutics Holdings, Inc. in?

    CERo Therapeutics Holdings, Inc. is in the Healthcare sector

    What industry is CERo Therapeutics Holdings, Inc. in?

    CERo Therapeutics Holdings, Inc. is in the Biotechnology industry

    What country is CERo Therapeutics Holdings, Inc. based in?

    CERo Therapeutics Holdings, Inc. is headquartered in United States

    When did CERo Therapeutics Holdings, Inc. go public?

    CERo Therapeutics Holdings, Inc.'s initial public offering (IPO) was on November 30, 2021

    Is CERo Therapeutics Holdings, Inc. in the S&P 500?

    No, CERo Therapeutics Holdings, Inc. is not included in the S&P 500 index

    Is CERo Therapeutics Holdings, Inc. in the NASDAQ 100?

    No, CERo Therapeutics Holdings, Inc. is not included in the NASDAQ 100 index

    Is CERo Therapeutics Holdings, Inc. in the Dow Jones?

    No, CERo Therapeutics Holdings, Inc. is not included in the Dow Jones index

    When does CERo Therapeutics Holdings, Inc. report earnings?

    The date for CERo Therapeutics Holdings, Inc.'s next earnings report has not been announced yet
    On this page